| 摘要 |
The present invention is related to compounds of Formula A or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further relates to pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as Leishmaniasis, Human African Trypanosomiasis and Chagas disease. |
| 申请人 |
IRM LLC;UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION;CHATTERJEE, ARNAB, KUMAR;LIANG, FANG;MATHISON, CASEY JACOB, NELSON;MISHRA, PRANAB KUMAR;MOLTENI, VALENTINA;NAGLE, ADVAIT, SURESH;SUPEK, FRANTISEK;TAN, LIYING, JOCELYN;VIDAL, AGNES;GELB, MICHAEL, HERMAN;BUCKNER, FREDERICK, SIMMONS;TATIPAKA, HARI, BABU;NORCROSS, RICHARD, NEIL;GILLESPIE, JOHN, ROBERT;PENDEM, NAGENDAR |
发明人 |
CHATTERJEE, ARNAB, KUMAR;LIANG, FANG;MATHISON, CASEY JACOB, NELSON;MISHRA, PRANAB KUMAR;MOLTENI, VALENTINA;NAGLE, ADVAIT, SURESH;SUPEK, FRANTISEK;TAN, LIYING, JOCELYN;VIDAL, AGNES;GELB, MICHAEL, HERMAN;BUCKNER, FREDERICK, SIMMONS;TATIPAKA, HARI, BABU;NORCROSS, RICHARD, NEIL;GILLESPIE, JOHN, ROBERT;PENDEM, NAGENDAR |
